Literature DB >> 28574864

Methadone Management of Withdrawal Associated With Loperamide-related Opioid Use Disorder.

Raphael J Leo1, Muhammad A Ghazi, Kelly S Jaziri.   

Abstract

: Loperamide hydrochloride is an over-the-counter anti-diarrheal agent, acting via mu-opioid receptor agonist effects in the intestinal myenteric plexus. Although preclinical investigations suggested that abuse liability associated with loperamide use is low, there are increasing numbers of cases reported to the US Food and Drug Administration, of abuse, dependence, and withdrawal associated with loperamide use. A case of a patient with opioid use disorder, that is, in the form of protracted loperamide excess use, requiring management of withdrawal with methadone is presented. Management of withdrawal from abrupt loperamide discontinuation has not been discussed in the literature. Long-term treatment issues are also described.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28574864     DOI: 10.1097/ADM.0000000000000325

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  2 in total

1.  Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced Activity.

Authors:  Vincent Guinchat; Nicolas Ansermot; Kuntheavy Ing Lorenzini; Dimitri Politis; Youssef Daali; Chin B Eap; Séverine Crettol
Journal:  Front Psychiatry       Date:  2022-06-23       Impact factor: 5.435

2.  Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports.

Authors:  Fabrizio Schifano; Stefania Chiappini
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.